Showing results (171-180 of 223) with videos related to
Sort By:
Pageof 23
Journal of Translational Medicine|August 31, 2011
An immunologic portrait of cancerMaria Libera Ascierto, Valeria De Giorgi, Qiuzhen Liu, et al.Plos One|June 20, 2014
Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesisSarah L May, Qing Zhou, Mitzi Lewellen, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2011
Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignanciesStephan Mielke, Zachariah A McIver, Aarthy Shenoy, et al.BMC Genomics|April 28, 2012
The stable traits of melanoma genetics: an alternate approach to target discoveryTara L Spivey, Valeria De Giorgi, Yingdong Zhao, et al.Clinical Hematology International|October 1, 2021
Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus InstrumentSandhya R Panch, Opal L Reddy, Katherine Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2019
Modulation of Target Antigen Density Improves CAR T-cell Functionality and PersistenceSneha Ramakrishna, Steven L Highfill, Zachary Walsh, et al.Blood|May 27, 2016
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignanciesMarianna Sabatino, Jinhui Hu, Michele Sommariva, et al.BMC Genomics|July 9, 2009
Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapyAndrea Worschech, Nanhai Chen, Yong A Yu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALLNirali N Shah, Daniel W Lee, Bonnie Yates, et al.Blood|July 15, 2016
T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myelomaSyed Abbas Ali, Victoria Shi, Irina Maric, et al.Pageof 23